These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase. Guo BC; Wei J; Su KH; Chiang AN; Zhao JF; Chen HY; Shyue SK; Lee TS Mol Nutr Food Res; 2015 Apr; 59(4):646-57. PubMed ID: 25581901 [TBL] [Abstract][Full Text] [Related]
7. Interferon-induced protein 35 inhibits endothelial cell proliferation, migration and re-endothelialization of injured arteries by inhibiting the nuclear factor-kappa B pathway. Jian D; Wang W; Zhou X; Jia Z; Wang J; Yang M; Zhao W; Jiang Z; Hu X; Zhu J Acta Physiol (Oxf); 2018 Jul; 223(3):e13037. PubMed ID: 29350881 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury. Sonnenschein K; Fiedler J; Pfanne A; Just A; Mitzka S; Geffers R; Pich A; Bauersachs J; Thum T Cardiovasc Res; 2019 Oct; 115(12):1804-1810. PubMed ID: 30843048 [TBL] [Abstract][Full Text] [Related]
10. TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction. Sun J; Pu Y; Wang P; Chen S; Zhao Y; Liu C; Shang Q; Zhu Z; Liu D Cardiovasc Diabetol; 2013 Apr; 12():69. PubMed ID: 23607427 [TBL] [Abstract][Full Text] [Related]
11. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity. Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480 [TBL] [Abstract][Full Text] [Related]
12. α7 Nicotinic acetylcholine receptor contributes to the alleviation of lung ischemia-reperfusion injury by transient receptor potential vanilloid type 1 stimulation. Li X; Xu Y; Cheng Y; Wang R J Surg Res; 2018 Oct; 230():164-174. PubMed ID: 30100034 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of neointimal formation with netrin-1 and netrin-1 preconditioned endothelial progenitor cells. Liu NM; Siu KL; Youn JY; Cai H J Mol Med (Berl); 2017 Mar; 95(3):335-348. PubMed ID: 28004124 [TBL] [Abstract][Full Text] [Related]
14. ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1. Kessler T; Zhang L; Liu Z; Yin X; Huang Y; Wang Y; Fu Y; Mayr M; Ge Q; Xu Q; Zhu Y; Wang X; Schmidt K; de Wit C; Erdmann J; Schunkert H; Aherrahrou Z; Kong W Circulation; 2015 Mar; 131(13):1191-201. PubMed ID: 25712208 [TBL] [Abstract][Full Text] [Related]
16. Deletion of Krüppel-like factor 4 in endothelial and hematopoietic cells enhances neointimal formation following vascular injury. Yoshida T; Yamashita M; Horimai C; Hayashi M J Am Heart Assoc; 2014 Jan; 3(1):e000622. PubMed ID: 24470523 [TBL] [Abstract][Full Text] [Related]
17. Coptisine inhibits neointimal hyperplasia through attenuating Pak1/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization. Chen Y; Jiang X; Yuan Y; Chen Y; Wei S; Yu Y; Zhou Q; Yu Y; Wang J; Liu H; Hua X; Yang Z; Chen Z; Li Y; Wang Q; Chen J; Wang Y Atherosclerosis; 2024 Apr; 391():117480. PubMed ID: 38447436 [TBL] [Abstract][Full Text] [Related]